MEDIA CONTACTS:
Susan Leigh or Jeanne Johnson
Phone: 202/371-9195, x144
Email: sleigh@aavmc.org or jjohnson@aavmc.org
WASHINGTON, D.C., February 3, 2022 – The American Association of Veterinary Medical Colleges (AAVMC) has named Dr. Barry T. Rouse, from the University of Tennessee College of Veterinary Medicine (UT-CVM), as the recipient of the 2022 AAVMC Excellence in Research Award.
Dr. Rouse is a UT Distinguished Professor and renowned researcher in the fields of viral immunology and immunopathology.
“The AAVMC is proud to recognize outstanding individuals like Dr. Rouse,” said AAVMC Chief Executive Officer Dr. Andrew T. Maccabe. “Their contributions inspire colleagues, provide a model for future generations of veterinarians and elevate the overall excellence of our member institutions. We look forward to honoring them during our 2022 annual conference.”
The AAVMC Excellence in Research Award designates the outstanding veterinary medical researcher of the year, as selected by a committee of peers. The AAVMC Board of Directors established the annual research award in 2010 to recognize outstanding research and scholarly achievements in the field of veterinary medicine. It recognizes an individual who, over the course of his or her career, has demonstrated excellence in original research, leadership in the scientific community, and mentoring of trainees and colleagues in any discipline of veterinary medicine.
Dr. Rouse primarily studies the herpes simplex virus (HSV) and how HSV can cause critical eye and nervous system tissue damage, with a view towards the development of therapeutics and vaccines.
He has received National Institute of Health (NIH) funding for more than four decades, with breakthroughs that include increasing understanding of how a particularly important subset of T-lymphocytes and T-regulatory cells in general contribute to viral disease. He has also identified new potential interventions to treat or prevent development of HSV-caused blindness, developed tools to measure HSV immunity, and pioneered the application of DNA vaccination to HSV infection. Currently, his research is exploring the value of manipulating metabolic pathways to change the outcome of viral diseases.
He has published over 425 peer-reviewed, scientific papers and book chapters, has a h-index of 89.9, presented over 190 seminars on his work, and mentored almost 80 postdoctoral fellows and gaduate students.
The award, which is sponsored by Elanco, will be presented during the AAVMC’s 2022 Annual Conference and Iverson Bell Symposium, which will be held in Washington, DC, March 3-5, 2022.
Download a photo of Dr. Rouse here.
About the AAVMC:
The member institutions of the American Association of Veterinary Medical Colleges (AAVMC) promote and protect the health and wellbeing of people, animals and the environment by advancing the profession of veterinary medicine and preparing new generations of veterinarians to meet the evolving needs of a changing world. Founded in 1966, the AAVMC represents more than 40,000 faculty, staff and students across the global academic veterinary medical community. Our member institutions include Council on Education (COE) accredited veterinary medical colleges and schools in the United States, Canada, Mexico, the United Kingdom, Europe, Asia, Australia, and New Zealand as well as departments of veterinary science and departments of comparative medicine in the U.S.
– 30 –
SHARE